|
Market Closed -
Singapore S.E.
11:20:32 30/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.0950 SGD | -.--% |
|
-24.00% | -75.00% |
| Market Cap | 15.82M 3.02M 2.36M 2.1M 1.96M 1.78M 3.36M 227M 3.39M 23.68M 9.17M 116M 8.86M 8.67M 372M | P/E 2024 |
11.1x | P/E 2025 | -15.3x |
|---|---|---|---|---|---|
| Enterprise Value | 27.2M 5.19M 4.06M 3.6M 3.36M 3.07M 5.78M 390M 5.84M 40.72M 15.78M 199M 15.23M 14.9M 640M | EV / Sales 2024 |
1.62x | EV / Sales 2025 | 1.76x |
| Free-Float |
21.36% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | -24.00% | ||
| 1 month | -24.00% | ||
| 3 months | -77.11% | ||
| 6 months | -73.24% | ||
| Current year | -75.00% |
| 1 week | 0.1 |  | 0.1 |
| 1 month | 0.1 | | 0.1 |
| Current year | 0.08 | | 0.42 |
| 1 year | 0.08 | | 0.45 |
| 3 years | 0.06 | | 0.7 |
| 5 years | 0.06 | | 0.7 |
| 10 years | 0.06 | | 0.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Xue Dan Wu
CEO | Chief Executive Officer | 63 | 31/12/2017 |
Pei Chan Tang
SEC | Corporate Secretary | - | - |
Moi Heyang Lin
SEC | Corporate Secretary | 59 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Heng Ching Chew
CHM | Chairman | 75 | 05/01/2009 |
Xue Dan Wu
BRD | Director/Board Member | 63 | 16/04/2004 |
Yong Teng Seow
BRD | Director/Board Member | 51 | 01/10/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -24.00% | -78.16% | -5.00% | 2.36M | |
| -0.61% | -3.43% | +36.07% | +117.61% | 1,019B | |
| -1.02% | -5.60% | +35.72% | +64.82% | 617B | |
| +1.11% | -0.58% | +12.36% | +78.27% | 464B | |
| +0.34% | -3.01% | +61.79% | +41.79% | 356B | |
| -0.95% | -4.05% | +20.54% | +40.33% | 333B | |
| -1.46% | -2.89% | +10.57% | +26.54% | 267B | |
| -1.35% | -5.43% | -6.17% | +8.82% | 244B | |
| -1.04% | -2.79% | +35.30% | +54.42% | 218B | |
| -1.87% | -4.10% | +28.44% | +97.54% | 179B | |
| Average | -0.68% | -3.05% | +15.65% | +52.51% | 369.72B | |
| Weighted average by Cap. | -0.60% | -3.33% | +29.07% | +71.15% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 67.65M 12.9M 10.09M 8.96M 8.37M 7.63M 14.38M 970M 14.52M 101M 39.24M 496M 37.88M 37.06M 1.59B | 43.75M 8.34M 6.53M 5.8M 5.41M 4.93M 9.3M 627M 9.39M 65.49M 25.38M 321M 24.5M 23.97M 1.03B |
| Net income | 8.28M 1.58M 1.23M 1.1M 1.02M 933K 1.76M 119M 1.78M 12.39M 4.8M 60.68M 4.64M 4.53M 195M | -4.3M -820K -641K -570K -532K -485K -914K -61.67M -923K -6.44M -2.49M -31.53M -2.41M -2.36M -101M |
| Net Debt | 11.66M 2.22M 1.74M 1.55M 1.44M 1.31M 2.48M 167M 2.5M 17.45M 6.76M 85.46M 6.53M 6.39M 274M | 11.38M 2.17M 1.7M 1.51M 1.41M 1.28M 2.42M 163M 2.44M 17.04M 6.6M 83.43M 6.37M 6.24M 268M |
Employees
1,096
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/09/26 | SGD 0.0950 | -.--% | 3,000 |
- Stock Market
- Stocks
- BFK Stock
Select your edition
All financial news and data tailored to specific country editions
